McKesson ROE 2010-2024 | MCK

Current and historical return on equity (ROE) values for McKesson (MCK) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
McKesson ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-06-30 $2.96B $-1.38B -193.21%
2024-03-31 $3.00B $-1.60B -200.63%
2023-12-31 $3.00B $-1.68B -204.08%
2023-09-30 $3.49B $-1.46B -222.06%
2023-06-30 $3.75B $-1.24B -247.20%
2023-03-31 $3.56B $-1.49B -226.03%
2022-12-31 $3.14B $-2.09B -190.31%
2022-09-30 $2.06B $-1.25B -155.09%
2022-06-30 $1.40B $-1.47B -134.94%
2022-03-31 $1.11B $-1.79B -164.37%
2021-12-31 $1.41B $-0.79B -759.14%
2021-09-30 $-4.81B $-0.09B 8217.09%
2021-06-30 $-4.50B $-0.05B -302.68%
2021-03-31 $-4.54B $0.18B -155.97%
2020-12-31 $-4.18B $-0.28B -99.77%
2020-09-30 $2.23B $6.09B 38.03%
2020-06-30 $0.92B $5.65B 15.33%
2020-03-31 $0.90B $5.31B 13.61%
2019-12-31 $-0.92B $6.39B -12.46%
2019-09-30 $-0.63B $6.69B -7.82%
2019-06-30 $0.60B $8.07B 6.75%
2019-03-31 $0.03B $8.29B 0.37%
2018-12-31 $-0.32B $9.39B -3.27%
2018-09-30 $0.12B $9.53B 1.15%
2018-06-30 $-0.38B $9.65B -3.53%
2018-03-31 $0.07B $10.06B 0.60%
2017-12-31 $4.80B $11.97B 41.64%
2017-09-30 $4.53B $11.36B 43.15%
2017-06-30 $4.84B $11.51B 48.06%
2017-03-31 $5.07B $11.27B 53.03%
2016-12-31 $1.91B $7.85B 21.27%
2016-09-30 $1.91B $9.62B 20.65%
2016-06-30 $2.22B $9.49B 24.49%
2016-03-31 $2.26B $9.01B 25.24%
2015-12-31 $1.96B $8.96B 22.48%
2015-09-30 $1.80B $8.87B 20.51%
2015-06-30 $1.65B $8.94B 17.97%
2015-03-31 $1.48B $8.09B 15.32%
2014-12-31 $1.71B $9.16B 16.82%
2014-09-30 $1.31B $10.53B 13.19%
2014-06-30 $1.24B $10.77B 13.39%
2014-03-31 $1.26B $10.32B 14.97%
2013-12-31 $1.15B $8.03B 15.11%
2013-09-30 $1.39B $7.99B 18.40%
2013-06-30 $1.38B $7.41B 18.52%
2013-03-31 $1.34B $7.07B 18.06%
2012-12-31 $1.60B $7.65B 21.77%
2012-09-30 $1.60B $7.72B 21.94%
2012-06-30 $1.50B $7.20B 20.93%
2012-03-31 $1.40B $6.83B 19.82%
2011-12-31 $1.30B $7.46B 18.17%
2011-09-30 $1.16B $7.12B 16.36%
2011-06-30 $1.19B $6.92B 16.98%
2011-03-31 $1.20B $7.22B 17.18%
2010-12-31 $1.13B $7.08B 15.94%
2010-09-30 $1.30B $6.82B 18.33%
2010-06-30 $1.27B $6.88B 18.02%
2010-03-31 $1.26B $7.53B 18.27%
2009-12-31 $1.20B $7.12B 18.19%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $71.233B $308.951B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $69.388B 18.80
Cardinal Health (CAH) United States $27.972B 15.17
West Pharmaceutical Services (WST) United States $23.854B 48.72
Cooper (COO) United States $20.668B 29.42
Labcorp (LH) United States $19.603B 16.25
Align Technology (ALGN) United States $16.786B 32.12
Henry Schein (HSIC) United States $8.871B 16.63
Merit Medical Systems (MMSI) United States $5.972B 30.50
DENTSPLY SIRONA (XRAY) United States $4.861B 13.03
CONMED (CNMD) United States $2.337B 19.50
Patterson (PDCO) United States $1.938B 10.23
STAAR Surgical (STAA) United States $1.521B 56.11
Lifevantage (LFVN) United States $0.175B 23.23
Pro-Dex (PDEX) United States $0.140B 27.95